Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin

Neuroinflammation in Alzheimer's disease: Current evidence and future directions

(2016) Valeria Calsolaro et al.   Alzheimers & Dementia

Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System

(2016) Jerzy Leszek et al.   CNS & Neurological Disorders-Drug Targets

Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity

(2016) L. I. Igel et al.   Current Atherosclerosis Reports

Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation

(2016) Sung Min Son et al.   JOURNAL OF ALZHEIMERS DISEASE

The Role of Ethnicity in Alzheimer’s Disease: Findings From The C-PATH Online Data Repository

(2016) Huei-Yang Chen et al.   JOURNAL OF ALZHEIMERS DISEASE

Diabetes medications: Impact on inflammation and wound healing

(2016) Jay J. Salazar et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D -galactose/AlCl 3 inducing rats model of Alzheimer’s disease

(2016) Hongyan Li et al.   JOURNAL OF ETHNOPHARMACOLOGY

Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db / db mice

(2016) Fang Chen et al.   NEUROPHARMACOLOGY

Metformin: A Hopeful Promise in Aging Research

(2016) Marta G. Novelle et al.   Cold Spring Harbor Perspectives in Medicine

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease

(2015) Yanxing Chen et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer’s disease

(2015) Douglas Walker et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

AMPK-mediated regulation of neuronal metabolism and function in brain diseases

(2015) Yu-Ju Liu et al.   JOURNAL OF NEUROGENETICS

Defining rehabilitation success in older adults with dementia–results from an inpatient geriatric rehabilitation unit

(2015) Susan W. Muir-Hunter et al.   Journal of Nutrition Health & Aging

Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism

(2015) Paweł Grieb   MOLECULAR NEUROBIOLOGY

Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway

(2015) Erli Zhang et al.   PLoS One

Senescence-accelerated OXYS rats: A model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease

(2014) Natalia Stefanova et al.   CELL CYCLE

The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD

(2013) Sally Hunter et al.   MOLECULAR NEUROBIOLOGY

Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease

(2013) Jayasankar Kosaraju et al.   NEUROPHARMACOLOGY

Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice

(2012) Jiejie Li et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Comparison of caffeine-induced locomotor activity between adolescent and adult rats

(2011) Marcelo T. Marin et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes

(2011) Ewan C. McNay et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease

(2011) Karim Bordji et al.   REVIEWS IN THE NEUROSCIENCES

Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis

(2010) Siddhartha Mondragón-Rodríguez et al.   Expert Review of Neurotherapeutics

Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress

(2010) K N Manolopoulos et al.   MOLECULAR PSYCHIATRY

Inflammation and the Redox-sensitive AGE-RAGE Pathway as a Therapeutic Target in Alzheimer's Disease

(2008) Annette Maczurek et al.   Annals of the New York Academy of Sciences